PASSIFLORE

Food supplement declared in France, declaration No 2024-1-1425, decision dated 29 January 2024

PASSIFLORE (MAJELIS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand: MAJELIS
Food business operator placing the product on the market: SAS MAJELIS
Status: Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form: Gélule
Daily dose: 2 gélules
Directions for use: 2 gélules par jour
Not recommended for (according to the manufacturer): Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims): Sommeil

Declaration 138603, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

Plant	Part	Preparation	Per day
Passiflora incarnata L.	Parties aériennes	Extrait sec aqueux	500 mg

Additives

E464, E470b

Other ingredients

maltodextrine

List from the declaration, administrative decision dated 29 January 2024 (Compl'Alim, food supplement declarations (France)).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes ou allaitantes.Pas avant 12 ans.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : MAJELIS